Pediatric asthma and COVID-19: The known, the unknown, and the controversial.

Authors:
Abrams EM; Sinha I; Fernandes RM; Hawcutt DB.

Journal:
Pediatr Pulmonol

Publication Year: 2020

DOI:
10.1002/ppul.25117

PMCID:
PMC7675412

PMID:
33058493

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pediatr Pulmonol

Abbreviation: Pediatr Pulmonol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A positive effect of a short period stay in Alpine environment on lung function in asthmatic childr…
Cogo A; Piazza M; Costella S and 6 more (2022) - Transparency Score: 3/6
A successful treatment of a lobar atelectasis in a patient with cystic fibrosis.
Daccò V; Sciarrabba CS; Corti F and 4 more (2022) - Transparency Score: 2/6
A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modu…
Kramer-Golinkoff E; Camacho A; Kramer L and 1 more (2022) - Transparency Score: 3/6
At-home end-tidal carbon dioxide measurement in children with invasive home mechanical ventilation.
Foster CC; Kwon S; Shah AV and 8 more (2022) - Transparency Score: 3/6
Collaborative decision-making: A framework for decision-making about life-sustaining treatments in …
Nageswaran S; Gower WA; Golden SL and 1 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTERESTS Elissa M. Abrams is a collaborator with the Institute for Health Metrics and Evaluation, is on the National Advisory Board for Food Allergy Canada, and has received honoraria from GSK and AstraZeneca. The other authors declare that there are no conflict of interests."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025